Functional effects of neuromelanin and synthetic melanin in model systems

Journal of Neural Transmission

Volumn 113, Issue 6, 2006, Pages 751-756

  Double, K L ^a  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

Melanin; Neuroprotection; Parkinson's disease

Indexed keywords

HORMONE DERIVATIVE; IRON; IRON CHELATING AGENT; NEUROMELANIN; TOXIC SUBSTANCE; TRANSITION ELEMENT;

APOPTOSIS; ARTICLE; CATECHOLAMINE NERVE CELL; CELL DAMAGE; CELL NUCLEUS; CELL PROTECTION; CHEMICAL STRUCTURE; EXPERIMENTAL MODEL; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IRON BINDING CAPACITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CELL SHAPE; HUMANS; MELANINS; MODELS, BIOLOGICAL; NEURONS; PARKINSON DISEASE; PIGMENTS, BIOLOGICAL; TYROSINE 3-MONOOXYGENASE;

EID: 33744944536     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0450-5     Document Type: Article

References (25)

1. Y Aimi PL [tmp] McGeer 1996 Lack of toxicity of human neuromelanin to rat brain dopaminergic neurons Parkinson Rel Disord 2 69 74
2. D Ben-Shachar P Riederer MBH Youdim 1991 Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease J Neurochem 57 1609 1614
3. D Ben-Shachar MB Youdim 1990 Selectivity of melanized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interaction J Neural Transm [Suppl] 29 251 258
4. MD Berg M Gerlach MBH Youdim KL Double L Zecca P Riederer G Becker 2001 Brain iron pathways and their relevance to Parkinson's disease J Neurochem 79 225 236
5. F Bolzoni S Giraudo L Lopiano B Bergamasco M Fasano PR Crippa 2002 Magnetic investigations of human mesencephalic neuromelanin Biochem Biophys Acta 1586 210 218
6. K Double P Riederer M Gerlach 1999 The significance of neuromelanin in Parkinson's disease Drug News Develop 12 333 340
7. K Double L Zecca P Costo M Mauer C Greisinger S Ito D Ben-Shachar G Bringmann RG Fariello P Riederer M Gerlach 2000 Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins J Neurochem 75 2583 2589
8. KL Double M Gerlach V Schünemann AX Trautwein L Zecca M Gallorini MBH Youdim P Riederer D Ben-Shachar 2003 Iron binding characteristics of neuromelanin of the human substantia nigra Biochem Pharmacol 66 489 494
9. KL Double GM Halliday J Henderson FM Griffiths T Heinemann P Riederer M Gerlach 2003 The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration Exp Neurol 184 530 535
10. M Fasano S Giraudo S Coha B Bergamasco L Lopiano 2003 Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein Neurochem Int 42 603 606
11. BA Faucheux ME Martin C Beaumont JJ Hauw Y Agid EC Hirsch 2003 Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease J Neurochem 86 1142 1148
12. H Fedorow F Tribl G Halliday M Gerlach P Riederer KL Double 2005 Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease Prog Neurobiol 75 109 124
13. E Hirsch A Graybiel Y Agid 1988 Melanized dopamine neurons are differentially susceptible to degeneration in Parkinson's disease Nature 28 345 348
14. W Korytowski T Sarna M Zareba 1995 Antioxidant action of neuromelanin: the mechanism of inhibitory effect on lipid peroxidation Arch Biochem Biophys 319 142 148
15. J Li C Scheller E Koutsilieri F Griffiths PM Beart LD Mercer G Halliday E Kettle D Rowe P Riederer M Gerlach M Rodriguez KL Double 2005 Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells J Neurochem 95 599 608
16. Y Liu L Hong V Kempf K Wakamatsu S Ito J Simon 2004 Ion-exchange and adsorption of Fe2(III) by Sepia melanin Pigment Cell Res 17 262 269
17. L Lopiano M Chiesa D Digilio G Giraudo B Bergamasco M Fasano 2000 Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients Biochem Biophys Acta 1500 306 312
18. D Offen I Ziv A Barzilai S Gorodin E Glater A Hochman E Melamed 1997 Dopamine-melanin induces apoptosis in PC12 cells; Possible implications for the etiology of Parkinson's disease Neurochem Int 31 207 216
19. B Pilas T Sarna B Kalyanaraman H Swartz 1988 The effect of melanin on iron associated decomposition of hydrogen peroxide Free Radic Biol Med 4 285 293
20. T Shima T Sarna H Swartz A Stroppolo R Gerbasi L Zecca 1997 Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study Free Radic Biol Med 23 110 119
21. H Wilms P Rosenstiel J Sievers G Deuschl L Zecca R Lucius 2003 Activation of microglia by human neuromelanin is NF-κB-dependent and involves p38 mitrogen-activated protein kinase: implications for Parkinson's disease FASEB J 17 500 502
22. M Youdim D Ben-Shachar P Riederer 1989 Is Parkinson's disease a progressive siderosis of substantia nigra resulting from iron and melanin induced neurodegeneration? Acta Neurol Scand 126 47 54
23. M Zareba A Bober W Korytowski L Zecca T Sarna 1995 The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems Biochem Biophys Acta 1271 343 348
24. L Zecca D Tampellini A Gatti R Crippa M Eisner D Sulzer S Ito R Fariello M Gallorini 2002 The neuromelanin of the human substantia nigra and its interaction with metals J Neural Transm 109 663 672
25. L Zecca FA Zucca H Wilms D Sulzer 2003 Neuromelanin of the substantia nigra: a neuronal block hole with protective and toxic characteristics Trends Neurosci 26 578 580